Inhibitor-Sensitive AmpC β-Lactamase Variant Produced by an Escherichia coli Clinical Isolate Resistant to Oxyiminocephalosporins and Cephamycins

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2004-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/AAC.48.7.2652-2658.2004PMID 15215122PMCID PMC434168
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• pKa measurements from nuclear magnetic resonance of tyrosine-150 in class C beta-lactamase.

  2003cited by this paper
• Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime.

  2002cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Detection of beta-lactamase-mediated resistance.

  2001cited by this paper
• Detection of β-lactamase-mediated resistance

  2001cited by this paper
• Structures of ceftazidime and its transition-state analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design.

  2001influential reference
• New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy.

  2001cited by this paper
• Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.

  2001cited by this paper
• A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan.

  2000cited by this paper
• Escherichia coli Mutants Lacking All Possible Combinations of Eight Penicillin Binding Proteins: Viability, Characteristics, and Implications for Peptidoglycan Synthesis

  1999influential reference
• Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion.

  1999cited by this paper
• Class A β-lactamases—enzyme-inhibitor interactions and resistance

  1999cited by this paper
• Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production.

  1999cited by this paper
• Molecular Basis of AmpC Hyperproduction in Clinical Isolates of Escherichia coli

  1999cited by this paper
• Class A beta-lactamases--enzyme-inhibitor interactions and resistance.

  1999cited by this paper
• Unusual tazobactam-sensitive AmpC-lactamase from two Escherichia coli isolates

  1998cited by this paper
• Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design.

  1998cited by this paper
• Unusual tazobactam-sensitive AmpC beta-lactamase from two Escherichia coli isolates.

  1998cited by this paper
• Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics.

  1997cited by this paper
• Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics

  1997cited by this paper
• An oligodeoxyribonucleotide-directed dual amber method for site-directed mutagenesis.

  1995cited by this paper
• Molecular Evolution of a Class C -Lactamase Extending Its Substrate Specificity (*)

  1995cited by this paper
• beta-Lactamases in laboratory and clinical resistance

  1995cited by this paper
• Determinants of the activity of beta-lactamase inhibitor combinations.

  1993cited by this paper
• Nitroimidazole drugs--action and resistance mechanisms. I. Mechanisms of action.

  1993cited by this paper
• Kinetic interactions of tazobactam with beta-lactamases from all major structural classes

  1993cited by this paper
• Evolution of an enzyme activity: crystallographic structure at 2-A resolution of cephalosporinase from the ampC gene of Enterobacter cloacae P99 and comparison with a class A penicillinase.

  1993cited by this paper
• Determinants of the activity of β-lactamase inhibitor combinations

  1993cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

  1990cited by this paper
• ampC beta-lactamase hyperproduction in Escherichia coli: natural ampicillin resistance generated by horizontal chromosomal DNA transfer from Shigella.

  1983cited by this paper
• Identification of a novel ampC beta‐lactamase promoter in a clinical isolate of Escherichia coli.

  1982cited by this paper
• The E. coli β-lactamase attenuator mediates growth rate-dependent regulation

  1981cited by this paper
• The E. coli beta-lactamase attenuator mediates growth rate-dependent regulation.

  1981cited by this paper
• ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type.

  1981influential reference
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper
• Isolation and characterization of DNA repetitions carrying the chromosomal β-lactamase gene of Escherichia coli K-12

  1979cited by this paper
• Isolation and characterization of DNA repetitions carrying the chromosomal beta-lactamase gene of Escherichia coli K-12.

  1979cited by this paper
• p K a measurements from nuclear magnetic resonance of tyrosine-150 in class C β-lactamase

  year unknowncited by this paper

• Molecular analysis of AmpC-producing Escherichia coli isolated from pediatric patients.

  2025cites this paper
• MSMEG_3978 (BlaE) from Mycobacterium smegmatis is an extended-spectrum beta-lactamase with a critical tyrosine residue governing its deacylation.

  2025cites this paper
• A Novel CMY Variant Confers Transferable High-Level Resistance to Ceftazidime-Avibactam in Multidrug-Resistant Escherichia coli

  2023cites this paper
• Analysis of BlaEC family class C beta-lactamase

  2023cites this paper
• Class C β-Lactamases: Molecular Characteristics

  2022cites this paper
• The biogenesis of β-lactamase enzymes

  2022cites this paper
• An extensive review on β-lactamase enzymes and their inhibitors.

  2022cites this paper
• Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol in Enterobacter cloacae Due to AmpC R2 Loop Deletion

  2020cites this paper
• Systematic research to overcome newly emerged multidrug‐resistant bacteria

  2020cites this paper
• Multiplex PCR to detect pAmpC β-lactamases among enterobacteriaceae at a tertiary care laboratory in Mumbai, India.

  2019cites this paper
• Characterisation of AmpC Hyper-Producing Escherichia coli from Humans and Dairy Farms Collected in Parallel in the Same Geographical Region

  2019cites this paper
• Etude des sites métalliques et modélisation de la réactivité des métallo-β-lactamases par des calculs de chimie quantique

  2017cites this paper
• Structural and Functional Aspects of Extended-Spectrum AmpC Cephalosporinases.

  2016cites this paper
• In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime

  2015cites this paper
• Emergence of Escherichia coli producing extended-spectrum AmpC β-lactamases (ESAC) in animals

  2014cites this paper
• Boronic acid-based enzyme inhibitors: a review of recent progress.

  2014cites this paper
• Resistance to ceftazidime in Escherichia coli associated with AcrR, MarR and PBP3 mutations and overexpression of sdiA.

  2014cites this paper
• Pisos dos parques infantis como fonte de contaminação microbiana

  2013cites this paper
• N152G, -S, and -T Substitutions in CMY-2 β-Lactamase Increase Catalytic Efficiency for Cefoxitin and Inactivation Rates for Tazobactam

  2013influential citation
• Hydrolysis Spectrum Extension of CMY-2-Like β-Lactamases Resulting from Structural Alteration in the Y-X-N Loop

  2012cites this paper
• Structural analysis of the Asn152Gly mutant of P99 cephalosporinase.

  2012cites this paper
• Functional studies of the interstrand cross-link repair protein, SNM1A and its beta-CASP domain

  2012cites this paper
• Current trends in β-lactam based β-lactamases inhibitors.

  2011cites this paper
• ACT-6, a novel plasmid-encoded class C β-lactamase in a Klebsiella pneumoniae isolate from China

  2011cites this paper
• Emergence of Ertapenem Resistance in an Escherichia coli Clinical Isolate Producing Extended-Spectrum β-Lactamase AmpC

  2011cites this paper
• Genetic and Biochemical Characterization of TRU-1, the Endogenous Class C β-Lactamase from Aeromonas enteropelogenes

  2010cites this paper
• A tripeptide deletion in the R2 loop of the class C beta-lactamase enzyme FOX-4 impairs cefoxitin hydrolysis and slightly increases susceptibility to beta-lactamase inhibitors.

  2010cites this paper
• Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.

  2010cites this paper
• New Disturbing Trend in Antimicrobial Resistance of Gram-Negative Pathogens

  2009cites this paper
• Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa

  2009cites this paper
• AmpC β-Lactamases

  2009cites this paper
• Structure of AmpC beta-lactamase (AmpCD) from an Escherichia coli clinical isolate with a tripeptide deletion (Gly286-Ser287-Asp288) in the H10 helix.

  2009cites this paper
• AmpC β-lactamases and bacterial resistance: an updated mini review

  2009cites this paper
• Reduced Susceptibility to Cefepime among Escherichia coli Clinical Isolates Producing Novel Variants of CMY-2 β-Lactamase

  2009cites this paper
• Novel Chimeric β-Lactamase CTX-M-64, a Hybrid of CTX-M-15-Like and CTX-M-14 β-Lactamases, Found in a Shigella sonnei Strain Resistant to Various Oxyimino-Cephalosporins, Including Ceftazidime

  2008cites this paper
• Phenotypic and Enzymatic Comparative Analysis of the Novel KPC Variant KPC-5 and Its Evolutionary Variants, KPC-2 and KPC-4

  2008cites this paper
• Epidemiology and Evolution of Beta-Lactamases

  2008cites this paper
• Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.

  2007cites this paper
• Small Molecule Inhibitors of a Glycoside Hydrolase Attenuate Inducible AmpC-mediated β-Lactam Resistance*

  2007cites this paper
• Extended-spectrum cephalosporinases: structure, detection and epidemiology.

  2007influential citation
• CARACTÉRISATION DES BETA-LACTAMASES ET LEUR INHIBITION PAR LES EXTRAITS DE PLANTES MÉDICINALES

  2007cites this paper
• Resistance to beta-Lactam Antibiotics Mediated by beta-Lactamases: Structure, Mechanism, and Evolution

  2007cites this paper
• Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistance.

  2007cites this paper
• Exact Location of the Region Responsible for the Extended Substrate Spectrum in Class C β-Lactamases

  2007cites this paper
• Screening of some medicinal plants from cameroon for β‐Lactamase inhibitory activity

  2007cites this paper
• Naturally Occurring Extended-Spectrum Cephalosporinases in Escherichia coli

  2006influential citation
• New beta-lactamases: a paradigm for the rapid response of bacterial evolution in the clinical setting.

  2006cites this paper
• Horizontal Transfer of blaCMY-Bearing Plasmids among Clinical Escherichia coli and Klebsiella pneumoniae Isolates and Emergence of Cefepime-Hydrolyzing CMY-19

  2006influential citation
• Practical Methods Using Boronic Acid Compounds for Identification of Class C β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli

  2005cites this paper
• Class C β-Lactamases: an increasing problem worldwide

  2004cites this paper
• Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.

  2004cites this paper